• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Surprise Result for Adherence in Bipolar Disorder
Research Update

Surprise Result for Adherence in Bipolar Disorder

November 9, 2023
Alex Evans, PharmD, MBA.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

Review of: Lintunen J et al, J Affect Disord 2023;333:403–408

Study Type: Retrospective cohort study

People with bipolar disorder vote with their feet when it comes to medication adherence. This study tallied those votes, using data from a large national pharmacy database.

Researchers enrolled 33,131 patients from Finland’s national health records database who were under age 65 and diagnosed with bipolar disorder between 1987 and 2018. Patients were included if they were prescribed mood stabilizers (lithium, valproic acid, or carbamazepine) or antipsychotics (27 agents were included) between 2015 and 2018. 

The primary outcome was nonadherence, which was defined as either 1) at least one medication not dispensed or 2) at least 20% of prescribed medication not dispensed. Researchers controlled for age, sex, time since bipolar disorder diagnosis, and number of previous hospitalizations due to bipolar disorder. They also controlled for other comorbidities, including mental health conditions like substance use disorder, anxiety, and personality disorders, as well as physical conditions like diabetes, cancer, and cardiovascular disease. These are worthy attempts, but without randomization the study cannot control for all the variables that may have skewed the results.

Around one in three patients were nonadherent to at least 20% of prescribed medication, and nearly twice that (59.1%) had at least one non-dispensed medication. Lithium fared best among the mood stabilizers, with 11.3% not dispensed, compared to at least 14% for the other mood stabilizers. Clozapine came out on top among antipsychotics, with 9% not dispensed, compared to 13.5%–31.4% for other antipsychotics (clozapine is used off label for treatment-resistant bipolar I disorder, and rates of clozapine prescription are higher in Finland than in other countries).

Risks for nonadherence included psychiatric comorbidities, younger age (under 25), recent onset (diagnosis within past three years), benzodiazepine usage, and multiple hospitalizations (four or more). 

Previous studies have found nonadherence rates of 20%–60% in bipolar disorder, often relying on problematic measures of self-report. Using a more objective measure, this study arrived at the high end of that range (59.1%), but this still may underestimate the problem. Just because a prescription is filled doesn’t mean it is taken. 

CARLAT TAKE

Surprisingly, lithium and clozapine had the highest rates of adherence in this study, countering their reputation as difficult medications that are burdened by stigma, side effects, and lab draws.

General Psychiatry Research Update
KEYWORDS adherence bipolar disorder clozapine lithium mood disorders
    Alex Evans, PharmD, MBA.

    Proposed Treatment Algorithm for Postpartum Psychosis

    More from this author
    www.thecarlatreport.com
    Issue Date: November 9, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Adult ADHD, TCPR, November/December 2023
    Binge Eating Disorder: Management and Treatment Options
    Adult ADHD Treatment Challenges
    Migraine in the Psychiatric Patient
    How Does Ketamine Compare to ECT in Treatment-Resistant Depression?
    Surprise Result for Adherence in Bipolar Disorder
    Age Matters in Antidepressant Response
    Health Benefits of a Silly Walk
    Mirtazapine Augmentation in OCD
    Can We Predict Suicidal Behaviors by Tracking Dreams?
    CME Post-Test Adult ADHD, TCPR, November/December 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.